title: Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
authors.affiliation: Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Mori
authors.affiliation: Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
authors.forename: Satoshi
authors.identifier: http://orcid.org/0000-0002-4716-8578
authors.initials: S
authors.lastname: Kuwabara
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D049349:Receptors, Lysosphingolipid / Q000037:antagonists & inhibitors*; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D049349:Receptors, Lysosphingolipid; D013844:Thiazoles; C550169:ponesimod
keywords: Multiple Sclerosis